Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Almac Expects High Sales Growth, Especially in U.S.
9:25 AM MST | February 25, 2008 | Alex Scott
Almac (Craigavon, U.K.), a privately owned pharmaceutical services group, says it is on track to grow sales significantly during the next few years and in the U.S. in particular. Group sales increased 16% in 2007, to £150.1 million ($293 million), and are expected to rise a further 20% this year, the company said at a press briefing, held recently at its Craigavon headquarters. Almac says its long-term goal is to expand its U.S. market presence. The firm’s largest single capital investment this year is a proposed $100-million project to build a U.S...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee